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Abstract  
Accidental or intentional ingestion of glyphosate surfactant-based herbicides, like 
Roundup, leads to nephrotoxicity as well as death. In this study, a panel of kidney 
injury biomarkers was evaluated in terms of suitability to detect acute kidney injury 
and dysfunction. The Roundup intoxication model involved oral administration of 
glyphosate to rats at dose levels of 250, 500, 1200 and 2500 mg/kg. Urinary and 
plasma biomarker patterns were investigated at 8, 24 and 48 hours after dosing. 
Biomarkers were quantified by absolute concentration; by normalising to urine 
creatinine; and by calculating the excretion rate. The diagnostic performances of each 
method in predicting of acute kidney injury were compared. By Receiver Operating 
Characteristic (ROC) analysis of the selected biomarkers, only urinary kidney injury 
molecule-1 (KIM-1) best predicted histological changes at 8 h (best cut-off point > 
0.00029 µg/ml). Plasma creatinine performed better than other biomarkers at 24 h 
(best cut-off point > 0.21 mg/dl). Urinary KIM-1 was the best early biomarker of 
kidney injury in this glyphosate-induced nephrotoxicity model.  
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creatinine, Roundup 
 
 
 
 
 
 
 
 
 
 
 
3 
 
1. Introduction 
Glyphosate [N-(phosphonomethyl) glycine, CAS # 1017-83-6] is the active 
ingredient in glyphosate-surfactant herbicides (GPSHs) which are used extensively as 
non-selective herbicides (Bradberry et al., 2004; Lee et al., 2009). GPSHs usually 
consist of glyphosate salts (e.g. isopropylamine/IPA, potassium, and di-ammonium 
salt), surfactant, anti-foaming agents, colour agents, biocides and inorganic ions for 
pH adjustment (Bradberry et al., 2004; Lee et al., 2009). Commercial products contain 
approximately 1 to 40%, or sometimes more, glyphosate (Bradberry et al., 2004; 
Roberts et al., 2010). Human intoxication with this herbicide results not only from the 
active ingredient but also from its complex and variable mixture. Thus 
polyoxyethyleneamine (POEA) is one of the surfactants extensively used and it has a 
toxic effect in its own right (Bradberry et al., 2004; Roberts et al., 2010). Glyphosate 
is one of the most commonly used herbicides in the world, especially in South East 
Asia (Cobb and Reade, 2010). Even though GPSHs are classified by the US 
Environmental Protection Agency as being in the least toxic category (IV), ingestion 
of a sufficient amount of GPSHs can lead to death, with reported case-fatality ranging 
from 3 to 30% (Ahsan et al., 2008; Chen et al., 2009; Lee et al., 2000; Nagami et al., 
2005; Roberts et al., 2010; Sawada et al., 1988; Talbot et al., 1991; Tominack et al., 
1991). The clinical outcomes of GPSH ingestion vary depending on the formulation, 
but include multi-organ toxicity, with nephrotoxicity, hepatotoxicity, gastrointestinal, 
cardiovascular and respiratory effects (Lee et al., 2008; Lee et al., 2009; Roberts et al., 
2010).  
Patients who die from GPSH ingestion generally develop acute kidney injury 
(AKI). The kidney may also be an organ for excretion of GPSH components (Moon 
and Chun, 2010; Roberts et al., 2010; Sribanditmongkol et al., 2012). Thus, early 
evidence of kidney injury could be used to predict the risk of a fatal outcome in GPSH 
toxicity.   
Plasma (pCr) or serum creatinine (sCr) and blood urea nitrogen (BUN) have 
usually been used as indicators, or biomarkers, for kidney injury in human GPSH 
intoxication (El-Shenawy, 2009; Lee et al., 2008; Moon and Chun, 2010; Talbot et al., 
1991; Tominack et al., 1991). Recently, several studies have suggested that pCr is not 
sensitive enough to detect early kidney injury or predict subsequent functional change 
(Sherwin et al., 2012; Toto, 1995; Vaidya et al., 2008b; Woitas et al., 2000). Other 
biomarkers including interleukin-18 (IL-18), cystatin-C (Cys-C), kidney injury 
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molecule-1 (KIM-1), 2-microglobulin (2-M), albumin (Alb), neutrophil gelatinase-
associated lipocalin (NGAL) and osteopontin (Opn) have been proposed for the early 
and sensitive detection of AKI and functional loss (Coca and Parikh, 2008; Coca et 
al., 2008; Ferguson et al., 2008; Nguyen and Devarajan, 2008; Noiri et al., 2009; 
Vaidya et al., 2008a; Vaidya et al., 2008b), and may have greater sensitivity than pCr. 
Some of these biomarkers are specific to the degree and site of kidney injury, while 
some indicate kidney dysfunction (e.g. Cys-C), but each biomarker shows a different 
time-profile after intoxication (Bonventre et al., 2010; Hoffmann et al., 2010). To the 
best of our knowledge, there is no systemic study comparing the performance of these 
markers for predicting GPSHs induced AKI.  
The current study aimed to find sensitive and specific biomarkers to diagnose the 
early phase of AKI and to localise the site of damage in rats after GPSH exposure. 
Fourteen candidate urinary biomarkers; uKIM-1, clusterin (uClu), uAlb, uβ2-M, uCys-
C, uNGAL, uOpn, vascular endothelial growth factor (uVEGF), tissue inhibitor of 
metalloproteinases (uTIMP-1), α-1-acid glycoprotein (uAPG), chemokine interferon-
inducible protein 10 (uIP-10), epidermal growth factor (uEGF), Calbindin-D28 (Cal) 
and alpha glutathione S-transferase (uGST-α) were examined in this study. The 
plasma biomarkers Cys-C (pCys-C) and NGAL (pNGAL) were also investigated. 
Biomarker patterns at different time points after treatment of different doses of 
glyphosate were defined and correlated to kidney injury (defined by histological 
changes) and kidney function (defined by creatinine level). Biomarkers were 
quantified in three different ways: absolute concentration, by normalising to urine 
creatinine (uCr) and by calculating the excretion rate. The diagnostic performances of 
each method in predicting of AKI were compared.  
 
2. Materials and methods 
2.1. Animals  
Male Wistar rats (200–250 g) were purchased from the Animal Resources Centre 
(Western Australia, Australia) and housed on a 12 h light/dark cycle.  The animals 
were allowed free access to food (standard laboratory chow) and water. Rats were 
fasted by withdrawing food overnight (12 h) before the experiments.  
2.2. Preparation of glyphosate solution 
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The commercial product of glyphosate (Concentrate Roundup® Weedkiller, 
Monsanto Australia Limited, Melbourne, Australia) containing 360 g/L of glyphosate 
as the isopropylamine salt was used in the study in a manner similar to previous 
published work (El-Shenawy, 2009; Lee et al., 2009; Talbot et al., 1991). It was 
diluted with water into 4 different concentrations (25, 50, 120 and 250 mg/ml) and 
was used for 4 different dose groups (250, 500, 1200 and 2500 mg/kg). The doses 
were chosen as being 5%, 10%, 25% and 50% of 7 day LD50 in rats (5000 mg/kg) 
(Williams et al., 2000). 
2.3. Experimental Design 
All experiments were approved by the University Animal Ethics Committee 
(Health Sciences) in the University of Queensland (AEC approval number: 
PAH/370/10/NHMRC). The rats were randomly divided into the 4 dose groups with 4 
rats in each group. Glyphosate solution was administered orally. Animal experiments 
were performed according to the OECD425 up-down procedure guideline (OECD, 
2008). Four rats were given only water and used as controls. After administration, rats 
were placed in individual metabolic cages and urine samples were collected on dry ice 
at intervals of 0-8 h, 8-24 h and 24-48 h. Blood was collected from the tail vein of 
each rat at 8 and 24 h. At 48 h, the rats were sacrificed and blood was collected from 
the vena cava. Blood samples were centrifuged at 3,000 rpm for 10 min at 4C to 
collect plasma. Plasma and urine samples were stored at -70C until biomarker 
analysis.  
2.4. Kidney biomarker analysis in urine and plasma 
The levels of Cr, Clu, Opn, KIM-1, β2-M, Cys-C, Alb, NGAL, Cal, GSTα, IP-10, 
TIMP-1, VEGF, AGP, EGF in urine and Cr, Cys-C NGAL in plasma were 
determined for control and glyphosate-treated animals.  
Cr levels in plasma and urine were determined by the Jaffe method using a 
Beckman DxC800 general chemistry analyser (Beckman Coulter, Fullerton, CA, 
USA), which was performed in the Chemical Pathology Department at the Princess 
Alexandra Hospital (Brisbane, Queensland, Australia).  
pNGAL and pCys C were quantified by ELISA [R and D Systems, Inc.] in batches 
following the manufacturer’s instructions. Urinary Clu, Opn, KIM-1, β2-M, Cys-C, 
Alb, NGAL ,Cal, GST-α, IP-10, TIMP-1, VEGF, AGP and EGF were determined 
using Millipore Milliplex Rat Mag Kidney Toxicity Panels 1 and 2 on the Luminex® 
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xMAP® platform (EMD Millipore Corporation, Billerica, MA, USA), following the 
manufacturer’s instructions. Intra- and inter-assay variability was lower than 10% and 
15%, respectively. These assays were performed by the Kidney Biomarker Research 
Group at the Prince of Wales Hospital, Sydney, NSW, Australia.  
2.5. Histological analysis 
The left kidney was removed from each animal and fixed in 10% neutral buffered 
formalin for 24 h, routinely embedded in paraffin, sectioned, then stained with 
hematoxylin and eosin or the in situ enzymatic assay ApopTag (ApopTag® 
Peroxidase In situ Apoptosis Detection Kit, Merck-Millipore Corporation, Billerica, 
MA) for evaluation of necrosis or apoptosis, respectively. ImageScope image 
analysis/viewer software version 10.1 (Aperio, Vista, CA) was used to analyse the 
digitally-scanned slides. Slides were viewed blinded to treatments and results 
reviewed under the supervision of an experienced pathologist. For each rat, twelve 
histological fields at x200 magnification were randomly selected in each slide and 
histological changes were quantified. Means from ten fields were used after excluding 
the lowest and highest values as outliers. Characteristics used to identify apoptosis 
included cellular rounding and shrinkage, nuclear chromatin compaction especially 
along the nuclear envelope in a crescentic manner, membrane-bound cellular blebbing 
and formation of apoptotic bodies. Characteristics for necrosis were cells with swollen 
eosinophilic cytoplasm, disrupted cell and organelle membranes, and lytic or densely 
pyknotic nuclear changes (Gobe, 2009). Necrotic and apoptotic cell counts per 
microscopic field were converted to cells per square millimetre in order to obtain 
quantitative determination of the degree of toxicity. Cell death was normalised for 
background cell death and was presented as normalised cell death.  
2.6. Data analysis  
Receiver Operating Characteristic (ROC) analysis was employed to compare and 
define biomarker performances (i.e. sensitivity and specificity) and was calculated for 
absolute biomarker concentration, biomarker normalised to uCr and biomarker 
excretion rate data obtained from control vs. treated animals and from animals 
without vs. those with abnormal histological findings in the kidney. An area under the 
curve (AUC)-ROC value of 0.9-1.0 indicates excellent performance, 0.8-0.89 good 
performance, 0.7-0.79 fair performance, 0.6-0.69 poor performance and < 0.6 
insignificant performance (Haase-Fielitz et al., 2009). The normalised biomarker 
concentrations were obtained by dividing the biomarker concentration (µg/ml) by the 
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uCr concentration (Cr levels were converted from mg/dl to µg/ml). Urinary biomarker 
excretion rates were calculated by: excretion rate (µg/h) = [concentration (µg/ml) 
×volume of urine (ml)]/time interval (h). 
The changes in Cr clearance, Cys C and NGAL apparent clearances were also 
determined as well as the correlation between Cr clearance and NGAL and Cys-C 
apparent clearances. Biomarker clearances were calculated by: biomarker clearance 
(ml/min/kg) = [urine flow rate (ml/min) × urine concentration of the biomarker 
(µg/ml)]/plasma concentration of the biomarker (µg/ml). 
2.7. Statistics 
As biomarker concentrations are not normally distributed, nonparametric analysis 
(Mann-Whitney rank-sum test) was used to compare histological changes and 
biomarker levels found in treatment groups with time-matched controls. Correlations 
between injury biomarkers and functional markers were determined using Spearman 
analysis with a 95% confidence interval. Significance was defined as p < 0.05. All 
statistical analyses were conducted using GraphPad Prism version 6.01 (GraphPad 
Software, San Diego, USA). Comparison of the AUCs was performed using the 
method described by Delong et al. (DeLong et al., 1988). 
 
3. Results   
3.1. Effect of Roundup treatment on kidney histology  
A significant increase in necrotic and apoptotic cells per mm2 was observed (Fig. 
1A and B). Necrotic and apoptotic cells were localised primarily in the tubular 
epithelium of the proximal straight tubule and thick ascending limb of the loop of 
Henle in the outer medulla than in nephron structures of the cortex. It should be noted 
that animals treated with 1200 and 2500 mg/kg of glyphosate showed severe 
dehydration and diarrhoea. A lower level of cell damage seen in these high dose 
groups (Fig. 1C) could be a result of low absorption of glyphosate and its surfactants 
via gut wall due to diarrhoea. In comparison with control kidney (Fig. 1D), 
Roundup administration induced marked histological changes, including proximal 
and distal tubular necrosis and glomerular toxicity (Fig. 1E and F) and apoptosis (Fig. 
1G). To our knowledge, this present study is the first to demonstrate apoptosis 
induced by Roundup  in an in vivo model of nephrotoxicity.   
3.2. Plasma biomarker changes in the Roundup-treated rats 
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As shown in Table 1 and Supplementary Fig.1, the level of all plasma biomarkers 
increased 1 day after Roundup ingestion, especially at the dose of 2500 mg/kg. In 
this dose group, pCr levels increased (1.7-fold the time-matched controls) as early as 
8 h after treatment. Moreover, pNGAL levels were increased 7-fold relative to 
controls after 8 h. Similarly, pCys-C levels increased between 1.9- and 2.4-fold after 8 
h.  
3.3. Urinary biomarker changes in the Roundup-treated rats 
Compared to control levels there was a significant increase in uKIM-1(3.2- and 
4.4-fold at 48 h for 500 and 2500 mg/kg of glyphosate, respectively), and uVEGF 
levels (13- and 20-fold) at the 24- and 48-h time points with 2500 mg/kg of 
glyphosate (p < 0.01, compared to control) as shown in Table 1 and Supplementary 
Fig.2. In the 250 mg/kg Roundup-treated rats group, no significant changes were 
observed for any biomarkers in both urine and plasma, although some histological 
changes were noted in this group of rats (Supplementary Fig. 3). For creatinine-
normalised biomarker concentrations, several urinary biomarkers including u2-M, 
uCys-C, uAlb, uKIM-1, uClu, uNGAL and uAGP showed significant responses to 
Roundup (Supplementary Fig. 4 and 5) after day 1 of exposure. The uCys-C:Cr and 
uAGP:Cr values elevated as early as 8 h after dosing (1.5- and 1.8-fold, respectively). 
Urinary 2-M:Cr, uAlb:Cr, uKIM-1:Cr and uNGAL:Cr values were elevated between 
2.4 and 4-fold relative to the control values within day 1. The urinary excretion rates 
did not significantly amplify the signal or improve detection of AKI for any 
biomarkers (Supplementary Fig. 6 and 7).  
3.4. Apparent biomarkers and creatinine clearances 
The changes in Cr clearance, Cys-C and NGAL apparent clearances and their 
correlation with each other are shown in Fig. 2A and B. There was a significant 
correlation between Cr clearance and apparent clearances of NGAL and Cys-C 
(Spearman r = 0.67 p  0.0001 and r = 0.50, p = 0.004 for NGAL and Cys-C, 
respectively). Plasma Cys-C levels directly correlated with pCr (Fig. 2C) (Spearman r 
= 0.48). However, pCys-C levels were not significantly related to Cr clearance (Fig. 
2D). There was no relationship between other urinary biomarker levels and pCr or Cr 
clearance. 
3.5. Kidney biomarker concentration-time profiles 
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The time profile of biomarker level changes after Roundup® ingestion is shown in 
Fig. 3. The biomarker levels at time 0 were obtained from the analysis of control rats. 
A normal range for each biomarker was defined as that biomarker’s level in the 
control group. The increase in uKIM-1, uClu, uVEGF and pCys-C, pNGAL and pCr 
demonstrated some dose-dependence, most obviously at the highest dose. Urinary 
KIM-1 levels and pCr (Fig. 3A and F) were higher than the normal range as early as 8 
h after Roundup dosing, and their levels increased until 48 h after dosing. Similarly, 
the uClu and uVEGF levels rose soon after dosing and remained higher than the 
baseline. For these biomarkers, however, this was found only in 2500 mg/kg of 
glyphosate dose group (Fig. 3C and E). In contrast, pNGAL and pCys-C levels only 
started to increase as late as 24 or 48 h after treatment (Fig. 3B and D).  
3.6. ROC analysis and biomarker performance 
Table 2 lists the injury biomarkers with excellent and good performance, based on 
ROC analysis. The AUC-ROCs were slightly variable for a given biomarker when 
comparing absolute urinary concentration, normalised concentration and excretion 
rate (Fig. 4). Urinary KIM-1 yielded the best performance at 8 h (AUC-ROC of 0.85) 
for the prediction of histological injury in kidney. Plasma Cr outperformed other 
biomarkers (AUC-ROC of 0.89 and 0.96 at 24 and 48 h, respectively) for the 
prediction of kidney damage after 24 h (Supplementary Fig. 8). Excretion rate and 
normalised biomarker concentration did not improve biomarker performances in the 
diagnosis and prognosis of AKI.  
 
4. Discussion  
In this study, biomarker and histological changes in the kidney were examined in 
rats after sub-lethal doses of Roundup to identify suitable biomarkers able to detect 
the early stages of kidney injury. The performances of biomarkers in the US-FDA 
approved kidney injury biomarker panel, proposed by the PSTC, were examined. This 
panel includes the conventional functional marker of kidney function (pCr) but also 
several biomarkers including uKIM-1 and uCys-C. There was no clear relationship 
between the degree of kidney injury and the concentrations of any plasma or urinary 
biomarkers. This indicates that any changes in biomarker levels did not closely reflect 
the amount of renal cell damage. However, uKIM-1 and pCys-C showed promise in 
potentially being able to detect histological AKI earlier than pCr. Histological 
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changes of Roundup toxicity have been reported previously (Sribanditmongkol et al., 
2012; Williams et al., 2000). However, in our investigation, we identified specific 
modes of cell death in necrosis and apoptosis. These modes of cell death occurred in 
tubules and glomeruli during the acute stages of Roundup toxicity. We believe our 
description of Roundup-induced apoptosis is novel..  
KIM-1 is a type I cell membrane glycoprotein expressed by tubule epithelial cells 
in response to injury. It appears in urine after proximal tubular injury (Ferguson et al., 
2008; Hoffmann et al., 2010; Vaidya et al., 2008a). In this study, uKIM-1 
outperformed other plasma and urinary biomarkers in early detection of AKI. 
However, as the specificity of this marker in predicting AKI is relatively low, there 
are limitations in terms of using uKIM-1 performance as an early biomarker in this 
animal model. Urinary KIM-1 gradually increased after Roundup dosing and levels 
greater than 0.00029 µg/ml indicated pathological changes with high sensitivity 
(100%) but low specificity (58%). A highly sensitive cut-off point is useful to exclude 
the presence of nephrotoxicity, such that levels below this cut-off point have high 
negative predictive value. Our study showed that using 0.00029 µg/ml of uKIM-1 as a 
cut-off value could exclude histological changes with 100% accuracy; whereas 42% 
of those with a uKIM-1 over this threshold were false positives (no histological 
change). Both sensitivity and specificity are relevant to assessment of the usefulness 
of a diagnostic method (Bewick et al., 2004). ROC analysis can guide selection of the 
optimal cut-point for decision-making. To confirm a diagnosis, high specificity (> 
95%) (Westin, 2001), or a high positive likelihood ratio is required (Bewick et al., 
2004). Although a cut-off of over 0.00044 µg/ml showed a very high likelihood ratio 
(LR = 7), only 60% of animals that had kidney damage were detected.  
However, at 24 h, pCr rose in the high dose group and remained high for 48 h. A 
concentration higher than 0.21 mg/dl was present in all cases with AKI. Although pCr 
concentration showed good performance (AUC-ROC of 0.89 at 24 h), the specificity 
for prediction of nephrotoxicity at 0.21 mg/dl was very low (44%), meaning 56% of 
those over this level were false positives. In other words, 56% of animals might have 
normal kidney histology and function. A cut-off point of > 0.28 mg/dl at 24 h gave 
the highest likelihood ratio (7.7), with 86% sensitivity and 90% specificity. It should 
be noted that Roundup induced myocardial cell hypertrophy (Cha et al., 2000), 
which causes myotoxicity possibly leading to an increase of pCr independent of AKI.  
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In either case our findings provide some mechanistic support for using pCr to detect 
GPSH toxicity and to predict mortality in acute GPSH-poisoning in humans (Lee et 
al., 2008). 
Some other biomarkers showed promise in AKI diagnosis including pCys-C, 
pNGAL and uVEGF. However, increases in these biomarkers were noted only at 24 h 
while pCr had already risen as early as 8 h after Roundup dosing. Cys-C is a 13-kDa 
protein that is freely filtered via the glomerulus but reabsorbed and degraded in 
lysosomes of proximal tubule cells. It is not secreted by kidney tubules (Ferguson et 
al., 2008; Vaidya et al., 2008a). Recently, serum or pCys-C levels were found to 
perform better than pCr in some patients as a surrogate measure of kidney function 
(GFR) . In this present study, pCys-C levels and pCr levels rose in a similar time-
dependent manner and appeared to be dose-dependent indicating that pCys-C could 
indicate kidney function, similar to pCr. Ideally, pCys-C is expected to increase 
earlier than pCr as it has a shorter half-life (Chiou and Hsu, 1975; Filler et al., 2005; 
Wyss and Kaddurah-Daouk, 2000). However, an increase in pCys-C levels was 
detected after pCr increased. This supports the idea of myotoxicity causing pCr 
increase.  
NGAL is expressed and secreted by kidney epithelial cells (Ferguson et al., 2008; 
Hoffmann et al., 2010; Lisowska-Myjak, 2010; Vaidya et al., 2008a). According to 
the ROC analysis, neither urinary nor plasma NGAL levels were good early markers 
of AKI in our rat model, even though an increase in pNGAL levels was found after 24 
h in rats treated with 2500 mg/kg of glyphosate. VEGF is an endothelial-specific 
growth factor involved in endothelial cell proliferation, differentiation and survival 
(Schrijvers et al., 2004). In rodent and human kidneys, VEGF is expressed 
predominantly in glomerular podocytes, distal tubules, and collecting ducts 
(Schrijvers et al., 2004). Therefore, uVEGF might be useful as an indicator for 
glomerular injury/dysfunction as this glycoprotein also regulates glomerular 
permeability (Breen, 2007; Schrijvers et al., 2004). The increase in uVEGF or 
uVEGF:Cr ratios could be a result of Roundup-induced podocyte injury. Finally, 
AGP is another one of the markers elevated (uAGP:Cr ratio) after high dose 
Roundup at 24 h in this study. This protein is an acute-phase glycoprotein produced 
primarily in the liver. An increase in AGP relates to several physiological states, for 
example; age, and pathological conditions including liver cirrhosis, nephritic disease 
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and acute inflammation (Bachtiar et al., 2009; Devarajan et al., 2010; Nickolas et al., 
2008; Williams et al., 1997). Thus, in the present study APG elevation may not 
specifically indicate acute kidney damage.  
The concentration of urinary biomarkers of AKI may be influenced by water 
reabsorption, urine flow rate and variation in urinary concentration within and 
between individuals (Ralib et al., 2012; Waikar et al., 2010). The ratio of biomarker 
over Cr (urine-Cr-normalised biomarker concentration) or the biomarker excretion 
rate has also been used for AKI prediction (Ilaria and Van, 1995; Ralib et al., 2012). 
GPSHs cause diarrhoea and gastrointestinal symptoms which can lead to dehydration 
and hypotension (Adam et al., 1997; Bradberry et al., 2004; Lee et al., 2008; Roberts 
et al., 2010). Even though normalised concentration slightly improved the statistical 
difference between poisoned rats and the time-matched controls, absolute 
concentration generally predicted AKI best, and the other two methods did not 
increase the ROC diagnostic performance. These results were similar to those 
presented in a previous study, a retrospective study of urinary biomarkers from the 
two-centre Early Intervention in Acute Renal Failure randomised controlled trail of 
high-dose erythropoietin for AKI prevention (Ralib et al., 2012).   
Limitations to this study include: 1) While sCr/pCr and Cr clearance are generally 
accepted as reasonable surrogate markers of GFR, they are subject to measurement 
error and it is possible that some toxic substances may affect Cr production or 
distribution. The true change in GFR was not evaluated using a gold standard method 
such as inulin clearance. 2) Kidney dysfunction (for example, of drug transporter 
function in the proximal or distal tubule) could happen before histopathological 
change is detectable (Bonventre et al., 2010). 3) It should be noted that a commercial 
mixture of glyphosate and surfactants was used in this current study, and the 
surfactant used in Roundup may contribute to herbicide nephrotoxicity (Seok et al., 
2011). Ingestion of more than 8 ml of undiluted surfactant strongly related to AKI 
development. The frequency of critical AKI was 17% after ingestion of 137.6±139.5 
ml glyphosate formulations (17-41% w/v of glyphosate) (Seok et al., 2011; Talbot et 
al., 1991).  
In conclusion, we examined whether a panel of biomarkers and a traditional 
biomarker (pCr) can predict early kidney injury following Roundup poisoning. The 
results showed a different time-course for each marker. By ROC analysis, uKIM-1 
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was the best biomarker at 8 h, predicting subsequent histological change in rats. 
However, the specificities of uKIM-1 and pCr performance for AKI prediction were 
relatively low. Plasma Cys-C mirrored kidney function in a similar way to pCr. 
However, pCr remains a worthwhile biomarker of early kidney injury and its 
usefulness should not be discounted in cases of nephrotoxicity. 
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Legends for Figures 
Fig. 1. Histopathological changes in the kidneys of male rats following oral 
Roundup administration, including necrotic cells and pyknotic nuclei (A), apoptotic 
cells (B) and total cell death (C). Each data point represents the mean ± SD of 6 rats. 
The means were calculated from average numbers of necrotic cells or apoptotic cells 
found in the cortex and medulla. Statistically significant changes from controls are 
indicated by * p < 0.05 and ** p < 0.01. Light micrographs of the kidneys from 
control (D) and Roundup groups (E,F) stained with hematoxylin-eosin. Nuclei of 
glomeruli (arrowhead) were often pyknotic (E). Areas containing necrosis 
(arrowhead) are visible in the hematoxylin-eosin stain in Roundup-treated sections 
(F). Tubular cells contain apoptotic nuclei (arrowhead) are visible in the Apoptag 
stain in Roundup-treated sections (G). Each bar indicates 100 µm.  
 
Fig. 2 Correlation (r) between apparent clearances of neutrophil gelatinase-associated 
lipocalin (A), cystatin-C (B) and creatinine clearance (Cr). Relationships between 
plasma cystatin-C and plasma creatinine (C), plasma cystatin-C and creatinine 
clearance (D). 
 
Fig. 3 Time-course of changes in injury biomarker concentrations. Urinary kidney 
injury molecule-1 (A), plasma neutrophil gelatinase-associated lipocalin (B), urinary 
clusterin (C) plasma cystatin-C (D),  urinary vascular endothelial growth factor (E) 
and plasma creatinine (F). The grey areas indicate normal ranges. The error bars 
represent IQR (n=4). 
 
Fig. 4 AUCs for the absolute urinary concentration, normalised urinary concentration, 
and urinary excretion rate. The mean AUCs with upper and lower 95% CI are 
presented. for urinary 2-microglobulin (A),  cystatin-C (B), albumin (C), clusterin 
(D), osteopontin (E), kidney injury molecule-1 (F), neutrophil gelatinase-associated 
lipocalin (G). * p < 0.05 for the difference between the AUC of normalised 
concentration or excretion rate and the absolute concentration. 
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Table 1 Levels of plasma and urinary renal biomarkers 
Biomarkers Dose (mg/kg) 0-8 h 8-24 h 24-48 h 
pNGAL (g/ml) 
Control 0.06±0.03 0.06±0.02 0.10±0.10 
250 0.06±0.01 0.20±0.26 0.08±0.02 
500 0.08±0.01 0.08±0.05 0.07±0.06 
1200 0.09±0.03 0.08±0.05 0.05±0.04 
2500 0.08±0.02 0.39±0.33*** 0.53±0.20** 
pCys-C (g/ml) 
Control 1.51±0.73 1.64±0.49 2.21±0.26 
250 1.17±0.08 1.64±0.09 2.20±0.75 
500 1.43±0.04 1.01±0.59 1.38±0.94 
1200 1.41±0.14 1.57±0.40 2.26±2.51 
2500 0.86±0.61 3.89±0.81*** 4.18±1.18 
pCr (mg/dl) 
Control 0.23±0.06 0.23±0.06 0.22±0.07 
250 0.21±0.02 0.27±0.04 0.25±0.11 
500 0.22±0.02 0.30±0.05* 0.32±0.18* 
1200 0.32±0.06 0.29±0.07 0.32±0.18 
2500 0.35±0.06* 0.58±0.08* 0.44±0.18** 
uKIM-1 (ng/ml) 
Control 0.44±0.24 0.30±0.09 0.29±0.12 
250 0.37±0.04 0.42±0.12 0.56±0.59 
500 0.40±0.10 0.49±0.33 0.92±0.32** 
1200 0.62±0.15 0.76±0.65 0.29±0.13 
2500 0.82±0.38 0.48±0.22 1.45±1.17** 
uVEGF (ng/ml) 
Control 0.34±0.15 0.20±0.01 0.22±0.10 
250 0.26±0.08 0.17±0.06 0.12±0.08 
500 - - - 
1200 0.12±0.15 0.23±0.06 0.14±0.12 
2500 0.60±0.36 4.07±1.60** 2.83±1.75** 
 
Statistically significant changes comparing to the controls are indicated by *p < 0.05 
and ** p < 0.01. p = plasma; u = urine; Cr = creatinine KIM-1 = kidney injury 
molecule-1; Cys-C = cystatin-C; NGAL = neutrophil gelatinase-associated lipocalin; 
VEGF = vascular endothelial-specific growth factor. 
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Table 2 Performance of absolute concentration biomarkers for prediction of AKI . 
Time-point Marker AUC Sensitivity (%) 
Specificity 
(%) 
Likelihood 
ratio Cut-off 
8 h 
uKIM-1 0.85 100 58 2.4 > 0.00029 µg/ml 
uKIM-1 0.85 92 66 2.8 > 0.00033 µg/ml 
uKIM-1 0.85 60 92 7.0 > 0.00044 µg/ml 
24 h 
pCr 0.89 100 44 1.8 > 0.21 mg/dl 
pCr 0.89 70 90 6.2 > 0.29 mg/dl 
pCr 0.89 63 100 - > 0.31 mg/dl 
48 h 
pCr 0.96 100 67 3 > 0.23 mg/dl 
pCr 0.96 86 90 7.7 > 0.28 mg/dl 
pCr 0.96 78 100 - > 0.29 mg/dl 
pCys-C 0.80 100 39 1.6 > 1.5 µg/ml 
pCys-C 0.80 79 61 2 > 1.7 µg/ml 
pCys-C 0.80 43 96 12 > 2.5 µg/ml 
pNGAL 0.78 100 25 1.3 > 4.2 µg/ml 
pNGAL 0.78 78 60 2 > 6.8 µg/ml 
pNGAL 0.78 60 96 16 > 9.2  µg/ml 
 
AUC = area under the curve; p = plasma; u = urine; Cr = creatinine KIM-1 = kidney 
injury molecule-1; Cys-C = cystatin-C; NGAL = neutrophil gelatinase-associated 
lipocalin 
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Supplementary Fig. 1. Plasma injury markers. Levels of plasma neutrophil gelatinase-associated 
lipocalin (A), plasma cystatin-C (B) and plasma creatinine (C) were measured in rats. Roundup was 
administered orally at glyphosate doses of 0 or 250 or 500 or 1200 or 2500 mg/kg to groups of 10 rats 
(zero/control group) and 4 rats (treatment groups). Time is indicated on the top and dose is indicated 
at the bottom. Circles indicate biomarker values from individual animals. Kidney histopathological 
assessment was performed at 48 h. The severity grades of necrotic cells and pyknotic nuclei after 
Roundup treatment are indicated on a scale of 1 (normal) to 7 with indicated grades displayed as 
the following colours: grade 1 (white), grade 2 (yellow), grade 3 (blue), grade 4 (green), grade 5 (red), 
grade 6 (purple) and grade 7 (black). The line indicates the mean for each group. Statistically 
significant changes are indicated by † p < 0.05 and †† p < 0.01. 
Supplementary Fig. 2 Urinary kidney 
injury biomarkers. Levels of urinary β2- 
microglobulin (A), urinary cystatin-C (B), 
urinary albumin (C), urinary kidney 
injury molecule-1 (D), urinary clusterin 
(E), urinary vascular endothelial growth 
factor (F) and urinary neutrophil 
gelatinase-associated lipocalin (G) were 
measured in rats. Roundup was 
administered orally at doses of 0 or 250 or 
500 or 1200 or 2500 mg/kg to groups of 
10 rats (zero/control group) and 4 rats 
(treatment groups). Time is indicated on 
the top and dose is indicated at the 
bottom. Circles indicate biomarker values 
from individual animals. Kidney 
histopathological assessment was 
performed at 48 h. Severity grades and 
statistically significant changes are as 
described under Supplementary Figure 1.
Supplementary Figure 3 
Urinary kidney injury biomarkers. 
Roundup was administered 
orally at doses of 0 or 250 or 500 
or 1200 or 2500 mg/kg to groups 
of 10 rats (zero/control group) and 
4 rats (treatment groups). 
Osteopontin (A), Calbindin-D28 
(B), tissue inhibitor of 
metalloproteinases (C), α-1-acid 
glycoprotein (D), epidermal 
growth factor (F). Time is 
indicated on the top and dose is 
indicated at the bottom. Circles 
indicate biomarker values from 
individual animals. Kidney 
histopathological assessment was 
performed at 48 h. Severity grades 
and statistically significant 
changes are as described under 
Supplementary Figure 1. 
 Supplementary Figure 4 
Normalisation of biomarkers to urine 
creatinine concentration. Ratios of 
urinary β2- macroglobulin to creatinine 
(A), urinary cystatin-C to creatinine 
(B), urinary albumin to creatinine (C), 
urinary kidney injury molecule-1 to 
creatinine (D), urinary clusterin to 
creatinine (E), urinary vascular 
endothelial growth factor to creatinine 
(F) and urinary neutrophil gelatinase-
associated lipocalin to creatinine (G) 
were measured in rats. Roundup was 
administered orally at doses of 0 or 250 
or 500 or 1200 or 2500 mg/kg to 
groups of 10 rats (zero/control group) 
and 4 rats (treatment groups). Time is 
indicated on the top and dose is 
indicated at the bottom. Circles indicate 
biomarker values from individual 
animals. Kidney histopathological 
assessment was performed at 48 h. 
Severity grades and statistically 
significant changes are as described 
under Supplementary Figure 1.
 Supplementary Figure 5  
Normalization to urine 
creatinine. Roundup was 
administered orally at doses of 
0 or 250 or 500 or 1200 or 
2500 mg/kg to groups of 10 
rats (zero/control group) and 4 
rats (treatment groups). 
Osteopontin (A), Calbindin-
D28 (B), tissue inhibitor of 
metalloproteinases (C), α-1-
acid glycoprotein (D), 
epidermal growth factor (F). 
Time is indicated on the top 
and dose is indicated at the 
bottom. Circles indicate 
biomarker values from 
individual animals. Kidney 
histopathological assessment 
was performed at 48 h. 
Severity grades and 
statistically significant changes 
are as described under 
Supplementary Figure 1. 
 Supplementary Figure 6 
Biomarker excretion rate. Excretion 
rate of urinary β2- macroglobulin 
(A), urinary cystatin-C (B), urinary 
albumin (C), urinary kidney injury 
molecule-1 (D), urinary clusterin 
(E), urinary vascular endothelial 
growth factor (F) and urinary 
neutrophil gelatinase-associated 
lipocalin (G) were measured in rats. 
Roundup was administered orally 
at doses of 0 or 250 or 500 or 1200 
or 2500 mg/kg to groups of 10 rats 
(zero/control group) and 4 rats 
(treatment groups). Time is 
indicated on the top and dose is 
indicated at the bottom. Circles 
indicate biomarker values from 
individual animals. Kidney 
histopathological assessment was 
performed at 48 h. Severity grades 
and statistically significant changes 
are as described under 
Supplementary Figure 1.
 Supplementary Figure 7 
Biomarker excretion rate. Roundup 
was administered orally at doses of 0 
or 250 or 500 or 1200 or 2500 mg/kg 
to groups of 10 rats (zero/control 
group) and 4 rats (treatment groups). 
Osteopontin (A), Calbindin-D28 (B), 
tissue inhibitor of metalloproteinases 
(C), α-1-acid glycoprotein (D), 
epidermal growth factor (F). Time is 
indicated on the top and dose is 
indicated at the bottom. Circles 
indicate biomarker values from 
individual animals. Kidney 
histopathological assessment was 
performed at 48 h. Severity grades 
and statistically significant changes 
are as described under 
Supplementary Figure 1. 
Supplementary Fig. 8 ROC curves for 
absolute concentration biomarkers at 0-8 
h (A) 8-24 h (B) and 24-48 h (C) with 
respect to a composite histopathology 
score for necrotic cells and pyknotic 
nuclei.  
 
 
